Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

TENAX THERAPEUTICS, INC. Director's Dealing 2016

Nov 29, 2016

34835_dirs_2016-11-29_7858dabb-77bc-4bb6-893b-dabdd1188e49.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2014-04-03

Reporting Person: PROEHL GERALD T (Director)

More from TENAX THERAPEUTICS, INC.

Declaration of Voting Results & Voting Rights Announcements 2026
Jun 4
Share Issue/Capital Change 2026
May 12
Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
May 12
Major Shareholding Notification 2026
May 9
Major Shareholding Notification 2026
May 7
Major Shareholding Notification 2026
May 7
Major Shareholding Notification 2026
May 4
Annual Report 2026
Apr 22
Proxy Solicitation & Information Statement 2026
Apr 22
View all filings →